{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:31:33Z","timestamp":1761154293124},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7572,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1023\/a:1008342828496","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"421-425","source":"Crossref","is-referenced-by-count":47,"title":["Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtype"],"prefix":"10.1016","volume":"10","author":[{"given":"A.","family":"Hasbini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mahjoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Chouaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Taamma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lianes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Cort\u00e8s-Funes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Armand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Cvitkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1023\/A:1008342828496_bb0005","first-page":"382","article-title":"Nasopharyngeal cancer: Epidemiology, staging and treatment","volume":"21","author":"Fandi","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008342828496_bb0010","article-title":"Cancer incidence in five continents","volume":"5","author":"Muir","year":"1987","journal-title":"IARC Sci Publ 88"},{"key":"10.1023\/A:1008342828496_bb0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.2910200403","article-title":"Relation between the EBV and indifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination","volume":"20","author":"Andersson-Anvret","year":"1977","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008342828496_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jso.2930330310","article-title":"Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients","volume":"33","author":"Ahmad","year":"1986","journal-title":"J Surg Oncol"},{"key":"10.1023\/A:1008342828496_bb0025","series-title":"Head and Neck Cancer Vol III. Experta Medica","first-page":"437","article-title":"Treatment of metastatic UCNT","author":"Cvitkovic","year":"1993"},{"key":"10.1023\/A:1008342828496_bb0030","first-page":"320","article-title":"5-FU, bleomycin, epirubicin and cisplatin in locally advanced recurrent and\/or metastatic UCNT: Preliminary activity and toxicity report","volume":"15","author":"Taamma","year":"1996","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008342828496_bb0035","first-page":"222","article-title":"Final report of a phase-II study of chemotherapy with bleomycin, epirubicin and cisplatin for locally advanced and metastatic\/recurrent UCNT","volume":"1","author":"Azli","year":"1995","journal-title":"Cancer J Sci Am"},{"key":"10.1023\/A:1008342828496_bb0040","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.1991.9.9.1675","article-title":"Chemotherapy of metastatic and\/or recurrent UCNT with cisplatin, bleomycm, and fluorouracil","volume":"9","author":"Boussen","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008342828496_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0277-5379(86)90386-X","article-title":"Phase-II study of a combination of hydroxyurea, fluorouracil and mitomycin m previously treated squamous cell carcinoma of head and neck","volume":"22","author":"Dodion","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1023\/A:1008342828496_bb0050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/1097-0142(19901001)66:7<1453::AID-CNCR2820660703>3.0.CO;2-X","article-title":"Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of head and neck region","volume":"66","author":"Fountzilas","year":"1990","journal-title":"Cancer"},{"key":"10.1023\/A:1008342828496_bb0055","first-page":"200","article-title":"5FU, mitomycin, epirubicin and cisplatin in recurrent and\/or metastatic UCNT","volume":"10","author":"Cvitkovic","year":"1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008342828496_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"Suppl 6","key":"10.1023\/A:1008342828496_bb0065","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1003::AID-CNCR1>3.0.CO;2-F","article-title":"The role of chemotherapy in the management of nasopharyngeal carcinoma","volume":"82","author":"Chan","year":"1998","journal-title":"Cancer"},{"key":"10.1023\/A:1008342828496_bb0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1023\/A:1008296203723","article-title":"UCNT: Chemocurable sometimes, but not very often","volume":"8","author":"Cvitkovic","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008342828496_bb0075","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/1097-0142(19911115)68:10<2120::AID-CNCR2820681005>3.0.CO;2-7","article-title":"Chemotherapy for recurrent or metastatic carcinoma of nasopharynx. A review of the Princess Margaret Hospital experience","volume":"68","author":"Choo","year":"1991","journal-title":"Cancer"},{"key":"10.1023\/A:1008342828496_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000227179","article-title":"Chemotherapy with cisplatin and continuous infusion of 5-fluorouracil and bleomycin for recurrent and metastatic nasopharyngeal carcinoma in Taiwan","volume":"50","author":"Su","year":"1993","journal-title":"Oncology"},{"key":"10.1023\/A:1008342828496_bb0085","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/0959-8049(92)90005-M","article-title":"Alternating chemo-radio-therapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced UCNT","volume":"28A","author":"Azli","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1008342828496_bb0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jnci\/82.7.616","article-title":"Complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy","volume":"82","author":"Bachouchi","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008342828496_bb0095","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1200\/JCO.1998.16.7.2514","article-title":"Phase-I\/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx","volume":"16","author":"Siu","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008342828496_bb0100","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19951201)76:11<2186::AID-CNCR2820761103>3.0.CO;2-Y","article-title":"Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for treatment of patients with nasopharyngeal carcinoma","volume":"76","author":"Chi","year":"1995","journal-title":"Cancer"},{"issue":"Suppl 4","key":"10.1023\/A:1008342828496_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/oxfordjournals.annonc.a057741","article-title":"Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience","volume":"1","author":"Gasmi","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008342828496_bb0110","article-title":"Long term disease-free survivors in metastatic UCNT","volume":"17","author":"Fandi","year":"1998","journal-title":"Pro Am Soc Clin Oncol"},{"issue":"Suppl 3","key":"10.1023\/A:1008342828496_bb0115","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0360-3016(95)00516-2","article-title":"UCNT: Current diagnostic and therapeutic aspects","volume":"32","author":"Altun","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008342828496_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1008279503428","article-title":"Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck","volume":"8","author":"Fountzilas","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008342828496_bb0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1008255220284","article-title":"Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer","volume":"9","author":"Au","year":"1998","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419571551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/4\/421\/19477369\/10-4-421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T23:29:46Z","timestamp":1582241386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419571551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["S0923753419571551"],"URL":"https:\/\/doi.org\/10.1023\/a:1008342828496","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}